Melanoma in Children, Adolescents, and Young Adults: The Spanish Cohort of the MELCAYA Consortium

• R.M. Patricio da Silva-Junior,
• J. Ficapal,
• M. Potrony,
• T. Torres,
• M.E. Gil,
• J. Bague,
• J. Mateu,
• F. Crespi-Payeras,
• S. Podlipnik,
• J.A. Puig,
• P. Aguilera,
• C. Carrera,
• L. Alòs,
• J. Malvehy,
• S. Puig

Affiliations

R.M. Patricio da Silva-Junior

Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Melanoma Unit, Barcelona, Spain

J. Ficapal

Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Melanoma Unit, Barcelona, Spain

M. Potrony

Hospital Clinic of Barcelona, Dermatology Department, Barcelona, Spain

T. Torres

Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Melanoma Unit, Barcelona, Spain; CIBER of Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain

M.E. Gil

Hospital Clinic of Barcelona, Dermatology Department, Barcelona, Spain

J. Bague

Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Melanoma Unit, Barcelona, Spain

J. Mateu

Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Melanoma Unit, Barcelona, Spain

F. Crespi-Payeras

Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Melanoma Unit, Barcelona, Spain; CIBER of Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain

S. Podlipnik

Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Melanoma Unit, Barcelona, Spain; Hospital Clinic of Barcelona, Dermatology Department, Barcelona, Spain

J.A. Puig

Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Melanoma Unit, Barcelona, Spain; Hospital Clinic of Barcelona, Dermatology Department, Barcelona, Spain; CIBER of Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain

P. Aguilera

Hospital Clinic of Barcelona, Dermatology Department, Barcelona, Spain

C. Carrera

Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Melanoma Unit, Barcelona, Spain; Hospital Clinic of Barcelona, Dermatology Department, Barcelona, Spain; CIBER of Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain; University of Barcelona, Barcelona, Spain

L. Alòs

Hospital Clinic of Barcelona, Dermatology Department, Barcelona, Spain

J. Malvehy

Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Melanoma Unit, Barcelona, Spain; Hospital Clinic of Barcelona, Dermatology Department, Barcelona, Spain; CIBER of Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain; University of Barcelona, Barcelona, Spain

S. Puig

Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Melanoma Unit, Barcelona, Spain; Hospital Clinic of Barcelona, Dermatology Department, Barcelona, Spain; CIBER of Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain; University of Barcelona, Barcelona, Spain